Approaching a Critical Juncture to Preserve the Oncology Enterprise
Robert L. Ferris, MD, PhD, pens this month's editor-in-chief column for Targeted Therapies in Oncology.| Targeted Oncology
Robert L. Ferris, MD, PhD, pens this month's editor-in-chief column for Targeted Therapies in Oncology.| Targeted Oncology
